Chen, J. W., Jacot, W., Cortés, J., Krop, I. E., Dent, S., Harbeck, N., . . . Wilson, T. R. (2023). ER+, HER2− advanced breast cancer treated with taselisib and fulvestrant: Genomic landscape and associated clinical outcomes. Wiley.
Chicago Style (17th ed.) CitationChen, Jessica W., et al. ER+, HER2− Advanced Breast Cancer Treated with Taselisib and Fulvestrant: Genomic Landscape and Associated Clinical Outcomes. Wiley, 2023.
MLA (9th ed.) CitationChen, Jessica W., et al. ER+, HER2− Advanced Breast Cancer Treated with Taselisib and Fulvestrant: Genomic Landscape and Associated Clinical Outcomes. Wiley, 2023.
Warning: These citations may not always be 100% accurate.